A joint effort by a team of academic and industrial researchers led by Associate Professor Yoshinori Yoshida (Department of Cell Growth and Differentiation) created a new modeling system, combining mechanical stretching and ...
Oct 18, 2023
0
40
If you've ever tried taking a picture of a puppy, you likely ended up with a blur of fur. Now try reading a stock ticker on the puppy's fur, and you'll have the challenge that faces researchers studying electrical conduction ...
Sep 11, 2023
0
50
Vigorous exercise does not appear to increase the risk of death or life-threatening arrhythmia for people with hypertrophic cardiomyopathy (HCM), according to a study supported by the National Institutes of Health. HCM is ...
May 17, 2023
0
45
Our genetic code includes more than 15,000 specific sections that can be made into molecules called lincRNAs. Some of these sections can occur in coiled-up sections of our genome called TADs. LincRNAs derived from TADs appear ...
Apr 26, 2023
0
16
A team of researchers from Illinois Institute of Technology and the University of Washington is trying to change the way that the field of biology understands how muscles contract.
Feb 2, 2023
0
136
The human heart is an intricate, complex organ and, like a car that starts sputtering, its function deteriorates for all sorts of reasons. Cardiomyopathy—any disease of the heart muscle that makes it pump blood less effectively—can ...
Oct 5, 2022
0
53
Nearly nine in ten cases of sudden cardiac death (SCD) due to hypertrophic cardiomyopathy (HCM) in young people are preceded by symptoms, ECG abnormalities or a positive family history, according to a new study published ...
Sep 14, 2022
0
67
Scientists from the Precision Cardiology Lab (PCL) of the Broad Institute of MIT and Harvard and Bayer have generated detailed maps of a variety of cell types in the heart that are involved in two major causes of heart failure: ...
Jun 23, 2022
0
118
Hypertrophic cardiomyopathy is a heart disease that leads to a stressed, swollen heart muscle. Due to a poor understanding of underlying mechanisms, effective clinical treatments are not available. Patients receive generic ...
May 11, 2022
0
51
Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to results from a recent clinical ...
Nov 17, 2021
0
75
